Editas Medicine's GAAP loss for 2021 was $192.502 million, up 66% from $115.976 million in the previous year. Revenue declined 71.8% to $25.544 million from $90.732 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept